Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $100.71 in the prior trading day, Incyte Corp (NASDAQ: INCY) closed at $100.91, up 0.20%. In other words, the price has increased by $0.20 from its previous closing price. On the day, 1.32 million shares were traded. INCY stock price reached its highest trading level at $101.71 during the session, while it also had its lowest trading level at $100.04.
Ratios:
Our goal is to gain a better understanding of INCY by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.76 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.55. For the most recent quarter (mrq), Quick Ratio is recorded 3.13 and its Current Ratio is at 3.20. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 19 ’25 when Tray Thomas sold 2,774 shares for $100.00 per share. The transaction valued at 277,400 led to the insider holds 22,973 shares of the business.
Tray Thomas sold 600 shares of INCY for $58,950 on Dec 18 ’25. The Principal Accounting Officer now owns 22,973 shares after completing the transaction at $98.25 per share. On Dec 19 ’25, another insider, VIJAY IYENGAR, who serves as the Officer of the company, bought 52,941 shares for $101.73 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INCY now has a Market Capitalization of 19810924544 and an Enterprise Value of 16922371072. As of this moment, Incyte’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.93, and their Forward P/E ratio for the next fiscal year is 13.03. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.12. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.12 while its Price-to-Book (P/B) ratio in mrq is 4.26. Its current Enterprise Value per Revenue stands at 3.516 whereas that against EBITDA is 12.779.
Stock Price History:
The Beta on a monthly basis for INCY is 0.82, which has changed by 0.44781482 over the last 52 weeks, in comparison to a change of 0.13927746 over the same period for the S&P500. Over the past 52 weeks, INCY has reached a high of $109.28, while it has fallen to a 52-week low of $53.56. The 50-Day Moving Average of the stock is 2.51%, while the 200-Day Moving Average is calculated to be 29.16%.
Shares Statistics:
The stock has traded on average 2.24M shares per day over the past 3-months and 2453640 shares per day over the last 10 days, according to various share statistics. A total of 196.13M shares are outstanding, with a floating share count of 194.30M. Insiders hold about 1.03% of the company’s shares, while institutions hold 103.65% stake in the company. Shares short for INCY as of 1764288000 were 9149380 with a Short Ratio of 4.08, compared to 1761868800 on 9517258. Therefore, it implies a Short% of Shares Outstanding of 9149380 and a Short% of Float of 6.569999999999999.
Earnings Estimates
. The current rating of Incyte Corp (INCY) reflects the combined expertise of 16.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $1.61, with high estimates of $1.9 and low estimates of $1.33.
Analysts are recommending an EPS of between $7.16 and $4.84 for the fiscal current year, implying an average EPS of $6.73. EPS for the following year is $7.7, with 20.0 analysts recommending between $9.33 and $5.38.
Revenue Estimates
18 analysts predict $1.35B in revenue for. The current quarter. It ranges from a high estimate of $1.43B to a low estimate of $1.3B. As of. The current estimate, Incyte Corp’s year-ago sales were $1.18BFor the next quarter, 18 analysts are estimating revenue of $1.25B. There is a high estimate of $1.36B for the next quarter, whereas the lowest estimate is $1.18B.
A total of 21 analysts have provided revenue estimates for INCY’s current fiscal year. The highest revenue estimate was $5.06B, while the lowest revenue estimate was $4.92B, resulting in an average revenue estimate of $4.98B. In the same quarter a year ago, actual revenue was $4.24BBased on 20 analysts’ estimates, the company’s revenue will be $5.52B in the next fiscal year. The high estimate is $5.82B and the low estimate is $5.13B.
